Prospective, Non-Interventional/Observational Registry of US Uterine Fibroids Patients (Capture-US) Save

Date Added
May 16th, 2017
PRO Number
Pro00065519
Researcher
David Soper
Keywords
Obstetrics and Gynecology
Summary

This study is try to understand current patients with fibroids and there choices for management. We will follow women through their journey and obtain patient reported outcomes, through questionnaire's, following their current therapies for Uterine Fibroids, including symptoms, quality of life, work productivity impact, and satisfaction.

Institution
MUSC
Recruitment Contact
Jordyn DeMartino
843-792-0349
demartij@musc.edu

A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women Save

Date Added
May 24th, 2016
PRO Number
Pro00055245
Researcher
David Soper
Keywords
Drug Studies, Obstetrics and Gynecology
Summary

The purpose of this study is to test how well patients with heavy menstrual bleeding associated with uterine fibroids respond to a medication called Elagolix. It aims to possibly find out how heavy menstrual bleeding associated with uterine fibroids and related conditions develop and progress and how they can be diagnosed, monitored, or treated, possibly develop tests to identify which patients are likely to have different diseases, respond to the study drug or drugs of the same or similar class, or to predict the progression of the heavy menstrual bleeding associated with uterine fibroids, and to possibly develop new therapies, research methods, or technologies. Participation in the study will last approximately 20 months.

Institution
MUSC
Recruitment Contact
Tamara Pfeffer
843-792-6323
paynej@musc.edu

Change_preferences

-- OR --

Create_login